Balyasny Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 2298 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 2270 |
|
2024
Q4 | – | Sell |
-13,574
| Closed | -$907K | – | 2211 |
|
2024
Q3 | $907K | Sell |
13,574
-26,802
| -66% | -$1.79M | ﹤0.01% | 1356 |
|
2024
Q2 | $4.79M | Buy |
40,376
+30,076
| +292% | +$3.57M | 0.01% | 831 |
|
2024
Q1 | $1.1M | Buy |
+10,300
| New | +$1.1M | ﹤0.01% | 1233 |
|
2023
Q4 | – | Sell |
-700,341
| Closed | -$72.3M | – | 2142 |
|
2023
Q3 | $72.3M | Buy |
700,341
+386,625
| +123% | +$39.9M | 0.15% | 142 |
|
2023
Q2 | $38.1M | Buy |
313,716
+308,504
| +5,919% | +$37.5M | 0.08% | 271 |
|
2023
Q1 | $800K | Sell |
5,212
-149,900
| -97% | -$23M | ﹤0.01% | 1411 |
|
2022
Q4 | $27.9M | Buy |
+155,112
| New | +$27.9M | 0.08% | 279 |
|
2022
Q3 | – | Sell |
-37,377
| Closed | -$5.34M | – | 2614 |
|
2022
Q2 | $5.34M | Buy |
+37,377
| New | +$5.34M | 0.02% | 726 |
|
2022
Q1 | – | Sell |
-66,529
| Closed | -$16.9M | – | 2350 |
|
2021
Q4 | $16.9M | Buy |
+66,529
| New | +$16.9M | 0.06% | 404 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1949 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 1914 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 1775 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1366 |
|
2020
Q3 | – | Sell |
-481,631
| Closed | -$30.9M | – | 1243 |
|
2020
Q2 | $30.9M | Buy |
+481,631
| New | +$30.9M | 0.27% | 76 |
|
2019
Q4 | – | Sell |
-11,557
| Closed | -$184K | – | 1229 |
|
2019
Q3 | $184K | Sell |
11,557
-37,420
| -76% | -$596K | ﹤0.01% | 960 |
|
2019
Q2 | $717K | Buy |
+48,977
| New | +$717K | ﹤0.01% | 1017 |
|